Mechanisms of action

Paracrine FGFs
Most paracrine FGFs are secreted proteins with cleavable N-terminal secreted signal peptides. However, FGF9, FGF16, and FGF20 have uncleaved bipartite secreted signal sequences (Revest et al., 2000) . By contrast, FGF1 and FGF2 without N-terminal signal sequences are not typical secreted proteins. They might be released from damaged cells or by an exocytotic mechanism that is independent of the endoplasmic reticulum-Golgi pathway (Mohan et al., 2010; Nickel, 2010) . Paracrine FGFs mediate biological responses as extracellular proteins by binding to and activating cell surface tyrosine kinase FGFR receptors (FGFRs) with heparin/heparan sulfate as a cofactor. The human/mouse Fgfr gene family comprises four Fgfr genes, Fgfr1-Fgfr4 (Beenken & Mohammadi, 2009; Turner & Grose, 2010) . All FGFR proteins are receptor tyrosine kinases of ~800 amino acids with an extracellular ligand-binding domain with three immunoglobulin-like domains (I, II, and III). Fgfr1-Fgfr3 encode two major versions of immunoglobin-like domain III (IIIb and IIIc) generated by alternative splicing that utilizes one of two unique exons. The immunoglobulin-like domain III is an essential determinant of ligand-binding specificity (Zhang et al., 2006) . Thus, seven major FGFR proteins (FGFRs 1b, 1c, 2b, 2c, 3b, 3c , and 4) with differing ligand-binding specificity are generated from four Fgfr genes. Paracrine FGFs have a heparin-binding site and interaction with heparin-like molecules is necessary for their stable interaction with FGFRs and local signaling . Paracrine FGFs function in development by influencing the intracellular signaling events of neighboring cells from a distance. The range of FGF signaling is regulated in part by affinity for extracellular matrix heparan sulfate proteoglycans (Kalinina et al., 2009) and in part by the dimerization of some FGFs (Kalinina et al., 2009; Harada et al., 2009) . The binding of FGFs to FGFRs induces functional dimerization, receptor transphosphorylation, and the activation of four key downstream signaling pathways: RAS-RAF-MAPK, PI3K-AKT, STAT, and PLCγ (Beenken & Mohammadi, 2009; Turner & Grose, 2010) .
Endocrine FGFs
Endocrine FGFs are also thought to mediate biological responses in an FGFR-dependent manner. However, they bind to FGFRs and heparin/heparan sulfate with very low affinity. The reduced heparin-binding affinity enables endocrine FGFs to function in an endocrine manner (Zhang et al., 2006; Goetz et al., 2007) . αKlotho is a single-pass transmembrane protein of ~1,000 amino acids with a short cytoplasmic domain. The phenotypes of αKlotho knockout mice are very similar to those of Fgf23 knockout mice (Shimada et al., 2004) , indicating that FGF23 and αKlotho may function in a common signal transduction pathway. αKlotho most efficiently binds to and activates FGFR1c among several isoforms of FGFRs in cultured cells, suggesting that FGFR1c can transduce an FGF23/αKlotho signal (Urakawa et al., 2006) . βKlotho is a protein that shares structural similarity and characteristics with αKlotho. The phenotypes of βKlotho knockout mice overlap those of Fgfr4 knockout mice and Fgf15/19 knockout mice (Ito et al., 2005; Inagaki et al., 2005) . FGF15/19 can bind to a βKlotho-FGFR4 complex in cultured cells. FGF15/19 also activates FGF signaling in hepatocytes that primarily express Fgfr4 . These results indicate FGFR4 to be the primary receptor for transduction of an FGF15/19/βKlotho signal. βKlotho is also essential for FGF21 signaling in cultured cells (Kharitonenkov et al., 2008) . However, Fgf21 knockout mouse phenotypes are distinct from βKlotho knockout mouse phenotypes (Ito et al., 2005; Hotta et al., 2009 ). In addition, the administration of recombinant human FGF21 to βKlotho knockout mice demonstrated that FGF21 signals can be transduced in the absence of βKlotho (Tomiyama et al., 2010) . These results indicate the existence of a βKlotho-independent FGF21 signaling pathway in which undefined cofactors might be involved.
Intracrine FGFs
Intracrine FGFs interact with intracellular domains of voltage-gated sodium channels and with a neuronal MAPK scaffold protein, islet-brain-2 (Schoorlemmer & Goldfarb, 2002; Goldfarb et al., 2007) . The only known role for intracrine FGFs is in regulating the electrical excitability of neurons and possibly other cell types (Goldfarb et al., 2007; Xiao et al., 2007; Shakkottai et al., 2009; Dover et al., 2010) .
Evolutionary history of the human/mouse Fgf gene family
The FGF signaling system has been conserved throughout metazoan evolution. Two Fgf-like genes have been identified in the nematode, C. elegans (Huang & Stern, 2005) . Six Fgf-like genes, which are potential ancestral genes of the human/mouse Fgf subfamilies, have been identified in the ascidian, C. intestinalis (Satou et al., 2002) . Ascidians belong to the Subphylum Urochordata, the earliest branch in the Phylum Chordata. These results indicate that most ancestral genes of the human/mouse Fgf subfamilies were generated by gene duplication after the diversion of protostomes and deuterostomes. The evolutionary history of the mouse Fgf family has been proposed ( Fig. 3 ) (Itoh & Ornitz, 2008 were generated from Fgf4-like by gene duplication. Fgf15/19-like was also generated from Fgf4-like by local gene duplication. Each subfamily further expanded into three or four members via two genome duplication events (R1 &R2) during the evolution of early vertebrates. The zebrafish Fgf family further expanded via an additional genome duplication event (R3) shortly after the teleost radiation.
The zebrafish FGF family
Almost all zebrafish orthologs of human/mouse Fgf genes except for Fgf9 have been identified. In addition, Fgf24 has been identified in zebrafish as well as all teleosts examined including the stickleback, medaka, and puffer fish. However, Fgf24 has not been identified in all tetrapods examined. These results indicate that Fgf9 and Fgf24 were lost in the teleost lineage and tetrapod lineage during evolution, respectively. Zebrafish also has six additional Fgf genes including Fgf6b, Fgf8b, fgf10b, fgf13b, fgf18b, and fgf20b. The zebrafish Fgf family comprises twenty-eight members. Analysis of the location of the additional genes indicates that they are paralogs ( Fig. 3 ) (Itoh & Konsihi, 2007) . Comparisons of mammalian genes with genes of teleost fish have shown that in teleosts, including zebrafish, there are often two homologs of the mammalian equivalent. This suggests that there has been an additional genome duplication event (R3) shortly after the teleost radiation. This duplication must have been either a partial or a whole genome duplication followed by rapid gene loss because gene duplications account for only ~20% of the zebrafish genes examined (Nusslein-Volhard et al., 2002) . Zebrafish Fgf paralogs were also generated by genome duplication.
Physiological roles of FGFs indicated by Fgf knockout mouse phenotypes
The mouse is a widely used mammalian model for studying functions of genes. Gene functions can be effectively blocked in mice by targeted disruption of genes. Gene knockout mouse phenotypes have indicated their physiological functions. Most Fgf genes have been disrupted in mice. Phenotypes range from early embryonic lethality to changes in adult physiology (Table 1) . Paracrine, endocrine, and intracrine FGFs mostly play roles in development, and metabolism, and neuronal functions, respectively.
Paracrine Fgfs
Paracrine FGFs are a major FGF group, canonical FGFs, including FGF1-FGF10, FGF16-FGF18, FGF20, and FGF22. Knockout mouse phenotypes mostly indicate roles as growth/differentiation factors. Fgf1 knockout mice are viable and normal (Miller, et al., 2000) . Fgf2 knockout mice are also viable, but have decreased vascular tone and reduced numbers of neurons in deep cortical layers (Raballo et al., 2000; Zhou et al., 1998; Dono et al., 1998) . In addition, Fgf2 knockout mice show impaired recovery from ischemic injury to the heart (House et al., 2003; Virag et al., 2007) . Fgf3 knockout mice are viable, but have phenotypes that include inner ear agenesis and dysgenesis, microtia, and microdontia (Mansour et al., 1993; Alvarez et al., 2003; Tekin et al., 2007) ). Fgf4 and Fgf8 knockout mice die at early embryonic stages. Fgf4 and Fgf8 have essential roles in blastocyst formation and gastrulation, respectively (Feldman et al., 1995; Sun et al., 1999) . Conditional inactivation of Fgf8 has identified additional roles in limb bud development and organogenesis. Fgf5, Fgf6, and Fgf7 knockout mice are viable. Abnormal long hair is observed in Fgf5 knockout mice (Hébert et al., 1994) . Fgf6 knockout mice have defects in muscle regeneration (Floss et al., 1997) . Fgf7 knockout mice have impaired hair and kidney development (Guo et al., 1996; Qiao et al., 1999) . Fgf9, Fgf10, and Fgf18 knockout mice die shortly after birth. Fgf10 is critical for epithelial-mesenchymal interactions necessary for the development of epithelial components of multiple organs (Min et al., 1998; Sekine et al., 1999; Ohuchi et al., 2000; Sakaue et al., 2002) . Fgf9 and Fgf18 have essential roles in the development of mesenchymal components of multiple organs (Colvin et al., 2001a,b; Colvin et al., 2001; Ohbayashi et al., 2002; Liu et ,al. 2002; Usui et al., 2004; Hung et al., 2007) . Fgf16 knockout mice on a C57BL/6 genetic background are viable, but have impaired embryonic cardiomyocyte proliferation (Hotta et al., 2008) . Fgf16 knockout phenotypes may be more severe on a Black Swiss genetic background where they die at embryonic day (E) 10.5 with severely impaired cardiac and facial development (Lu et al., 2008; Lu et al., 2010) . Fgf17 and Fgf22 knockout mice are viable, but show impaired hindbrain development and impaired synaptic differentiation, respectively (Xu et al., 2000; Terauchi et al., 2010) . In addition, Fgf22 knockout mice also show a clear delay in weight gain upon sexual maturity (Grose et al., unpublished data). Although roles of paracrine FGFs in embryogenesis have been revealed from knockout mouse phenotypes, their contributions to adult physiology remain relatively unexplored. The widespread expression of paracrine Fgf genes in adult tissues suggests multiple roles in tissue homeostasis and repair (Fon Tacer et al., 2010) . Emerging reports indicate homeostatic and regenerative roles for paracrine FGF signaling (Böhm et al., 2010; Yang et al., 2010) .
Endocrine Fgfs
Endocrine FGFs, FGF15/19, FGF21, and FGF23, are hormone-like FGFs. Hormones are usually responsible for communication between tissues in an endocrine manner. However, several hormones are produced in developing tissues that are unrelated to the endocrine gland of origin in adults. These hormones are synthesized locally, and serve as differentiation factors in embryos (Sanders & Harvey, 2008) . Endocrine FGFs also act as differentiation factors in embryos and as hormones in adults (Itoh, 2010 
Intracrine Fgfs
Intracrine FGFs, FGF11-FGF14, are intracellular proteins. Fgf14 knockout mice are viable. However, they develop ataxia and a paraoxysmal hyperkinetic movement disorder (Goldfarb et al., 2007; Xiao et al., 2007; Shakkottai et al., 2009 ). In contrast, Fgf12 knockout mice are apparently normal. Fgf12/Fgf14 double knockout mice show severe ataxia and other neurological deficits (Goldfarb et al., 2007) . Phenotypes of Fgf11 and Fgf13 knockout mice have not been reported.
Roles of FGFs indicated by Fgf mutated or knockdown zebrafish phenotypes
The zebrafish is also a widely used vertebrate model for studying functions of genes. Because zebrafish embryos are small, the fertilization and subsequent embryonic development occur externally, and the development is rapid (Nusslein-Volhard et al., 2002), phenotypes of zebrafish embryos in which the functions of genes are blocked-the knockout of which is lethal at early embryonic stages in mice-can be potentially analyzed. In a largescale screening, many zebrafish mutants, which were mutagenized with ethylnitrosourea, displaying distinct phenotypes in embryos were generated (Haffter et al., 1996) . Furthermore, antisense morpholino oligonucleotides can easily block the functions of multiple genes in zebrafish embryos (Nasevicius & Ekker, 2000) . Therefore the zebrafish is www.intechopen.com
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Paracrine FGFs
Several zebrafish paracrine Fgf mutants have been generated by mutagenesis with ethylnitrosourea. acerebellar is a mutation of Fgf8. acerebellar embryos lack a cerebellum and the midbrain-hindbrain boundary organizer (Reifers et al., 1998) . ikarus is a mutation of Fgf24. ikarus embryos lack pectoral fin buds (Fischer et al., 2003) . daedalus is a mutation of Fgf10. Daedalus embryos have no pectoral fin buds either and a severely dysmorphic hepatopancreatic ductal system (Norton et al., 2005; Dong et al., 2007) . devoid of blastema is a mutation of Fgf20a. devoid of blastema embryos have no pectoral fin buds (Whitehead et al., 2005) . These results indicate that zebrafish fgfs also play crucial roles in development. Several paracrine Fgf knockdown zebrafish embryos were generated using antisense morpholino oligonucleotides. Phenotypes of these embryos indicate roles of Fgfs in zebrafish. FGF1 is required for normal differentiation of erythrocytes (Songhet et al., 2007) . FGF3 and FGF8 are required together for formation of the otic placode and vesicle (Maroon et al., 2002) . FGF4 is required for left-right patterning of visceral organs (Yamauchi et al., 2009 ). In addition, FGF16 is also required for the fin buds to form (Nomura et al., 2006) .
Endocrine FGFs
Fgf15/19 and Fgf21 knockdown zebrafish embryos were generated using antisense morpholino oligonucleotides. FGF15/19 and FGF21 are required for the forebrain and eye to develop (Miyake et al., 2005; Nakayama et al., 2008) , and hematopoiesis (Yamauchi et al., 2006) .
FGF signaling disorders in human diseases
As described above, FGF signaling is crucial to development, metabolism, and neuronal functions as paracrine, endocrine, and intracrine factors. In addition, FGF signaling disorders also result in human hereditary, paraneoplastic, and metabolic diseases.
Paracrine FGFs
Michel aplasia is a unique autosomal recessive syndrome characterized by type I microtia, microdontia, and profound congenital deafness associated with a complete absence of inner ear structures. Michel aplasia is caused by mutations in Fgf3 (Tekin et al., 2007) . Nonsense mutations in Fgf8 are found in familial isolated hypogonadotropic hypogonadism with variable degrees of gonadotropin-releasing hormone deficiency and olfactory phenotypes. These findings confirm that loss-of-function mutations in Fgf8 cause human gonadotropinreleasing hormone deficiency (Trarbach et al., 2010) . Cleft lip and/or palate (CLP) appear when the two halves of the palatal shelves fail to fuse completely. A missense mutation in Fgf8 was found in a patient with CLP. This mutation is predicted to cause loss-of-function by destabilizing the N-terminal conformation, which is important for FGFR binding affinity and specificity (Riley et al., 2007) . Aplasia of lacrimal and salivary glands (ALSG) is an autosomal dominant congenital anomaly characterized by aplasia, atresia, or hypoplasia of the lacrimal and salivary systems. Lacrimo-auriculo-dento-digital syndrome (LADD) is an autosomal-dominant multiple congenital anomaly disorder characterized by aplasia, atresia, or hypoplasia of the lacrimal and salivary systems, cup-shaped ears, hearing loss, and dental and digital anomalies. Both ALSG and LADD are caused by Fgf10 mutations (Entesarian et al., 2007; Rohmann et al., 2006) . Fgf20 was originally identified as a neurotrophic factor preferentially expressed in dopaminergic neurons within the substantia nigra pars compacta of rat brain (Ohmachi et al., 2003) . Parkinson disease (PD) is caused by a pathogenic process responsible for the loss of dopaminergic neurons within the substantia nigra pars compacta. A pedigree disequilibrium test and a case-control association study indicated that Fgf20 is potentially a risk factor for PD (Gao et al., 2008) .
Endocrine FGFs
Serum FGF15/19 levels are markedly increased in patients with extrahepatic cholestasis caused by a pancreatic tumor. FGF15/19 is abundantly expressed in the liver of cholestatic patients, but not in the normal liver. FGF15/19 signaling may be involved in some of the adaptations that protect the liver against bile salt toxicity (Schaap et al., 2009) . Serum FGF15/19 levels are also significantly increased in patients on chronic hemodialysis (Reiche et al., 2010) . Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome, and ranges from simple fatty liver to nonalcoholic steatohepatitis. Its prevalence has increased dramatically over recent years in developed countries (Morris-Stiff & Feldstein, 2010) . The pathophysiological hallmark of NAFLD is insulin resistance. NAFLD may increase the risk of type 2 diabetes and atheroclerosis (Bugianesi et al., 2010) . Hepatic lipid metabolism is disturbed in patients with NAFLD. The hepatic response to FGF15/19 is impaired in NAFLD patients with insulin resistance. This impaired response may contribute to the disturbance of lipid homeostasis in NAFLD (Schreuder et al., 2010) . Serum FGF21 levels are significantly increased in NAFLD (Yilmaz et al., 2010; Dushay et al., 2010; Li et al., 2010) . Serum FGF21 levels are positively correlated with intrahepatic triglyceride levels . As NAFLD is now recognized as a major public health problem, reliable biomarkers for NEFLD are needed. Serum FGF21 levels might be useful as a biomarker for NEFLD (Morris-Stiff & Feldstein, 2010) . Type 2 diabetes connected with visceral obesity and insulin resistance has become a global health concern. Serum FGF21 levels are increased in patients with type 2 diabetes, gestational diabetes, and obesity, indicating FGF21 to be a potential new marker in patients with type 2 diabetes (Table 1 ) (Chen et al., 2008; Zhang et al., 2008; Chavez et al., 2009; Mraz et al., 2009; Stein et al., 2010; Matuszek et al., 2010) . Serum FGF21 levels are independently associated with markers of insulin resistance and an adverse lipid profile (Chen et al., 2008; Stein et al., 2010) . The upregulation of serum FGF21 levels might be a compensatory mechanism to improve glucose metabolism when insulin resistance is present. Impaired glucose tolerance (IGT) is an important category of prediabetes. Serum FGF21 levels were also increased in Chinese subjects with IGT, however, they did not correlate with insulin resistance (Li et al., 2009 ). Cushing's syndrome is a hormone disorder caused by high levels of cortisol (hypercortisolism) in the blood. Patients with Cushing's syndrome frequently suffer from visceral obesity, insulin resistance/diabetes, and other abnormalities similarly to patients with metabolic syndrome. Serum FGF21 levels are also increased in patients with Cushing's syndrome. The increased FGF21 levels are due to excessive fat accumulation and related metabolic abnormalities rather than a direct effect of cortical on FGF21 production (Durovcová et al., 2010) . Lipodystrophy is a common alteration in HIV-1-infected patients under anti-retroviral treatment. This syndrome is usually associated with peripheral lipoatrophy, central adiposity, and, in some cases, lipomatosis, as well as systemic insulin resistance and hyperlipidemia (Villarroya et al., 2007) . Serum FGF21 levels are increased in HIV-1-infected patients with lipodystrophy. This increase is closely associated with insulin resistance, metabolic syndrome, and markers of liver damage. FGF21 might be a biomarker of altered metabolism in HIV-1-infected, antiretroviral-treated patients (Domingo et al., 2010) . Serum FGF21 levels correlate with renal function and are markedly increased in chronic kidney disease patients receiving hemodialysis, suggesting a possible link between their FGF21 levels and renal function (Stein et al., 2009) . Patients with end-stage renal disease (ESRD) show insulin resistance. Serum FGF21 levels are also markedly increased in patients with ESRD, suggesting FGF21 to play a role in insulin resistance in these patients (Han et al., 2010) . Autosomal dominant hypophosphatemic rickets (AHDR) is caused by gain-of-function mutations of Fgf23 (ADHR Consortium, 2000) . FGF23 is partially cleaved by intracellular proteolysis. The cleaved forms lose their biological activity. Fgf23 mutations in ADHR result in impaired proteolysis of FGF23 and increased serum levels of active FGF23 (White et al., 2001) . Reduced FGF23 signaling also causes human hereditary diseases. Familial tumoral calcinosis (FTC) is characterized by ectopic calcification and hyperphosphatemia. Loss-offunction mutations of Fgf23 result in FTC. These mutations destabilize the tertiary structure of FGF23 and increase its susceptibility to degradation (Benet-Pagès et al., 2005) . Tumors that over-produce FGF23 also cause tumor-induced osteomalacia, which is a paraneoplasitc disease characterized by hypophosphatemia caused by renal phosphate wasting (Shimada et al., 2001) . Serum FGF23 levels are also greatly increased in patients with renal failure, partly owing to decreased renal clearance. These results suggest that FGF23 has a compensatory role in the disease (Larsson et al., 2003) .
Intracrine FGFs
Börjeson-Forssman-Lehmann syndrome (BFLS) is a syndromic X-linked mental retardation disease. Fgf13 is a candidate causative gene for BFLS (Gecz et al., 1999) . Hereditary spinocerebellar ataxias (SCAs) are a clinically and genetically heterogeneous group of neurodegenerative disorders. One SCA with early-onset tremors, dyskinesia, and slowly progressive cerebellar ataxia is caused by Fgf14 mutations (van Swieten et al., 2003; Brusse et al., 2006; Misceo et al., 2009 ).
Conclusion
The human/mouse FGF family comprises twenty-two members, which were generated by gene duplication after the diversion of protostomes and deuterostomes and two genome duplication events (R1 and R2) during the evolution of early vertebrates. In contrast, the zebrafish FGF family comprises twenty-eight members including several paralogs, which were generated by an additional genome duplication event (R3) in the teleost lineage during evolution. 
Acknowledgements
This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan and the Takeda Science Foundation, Japan. 
References
